{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-025365","form_type":"8-K","ticker":"ABT","cik":"0000001800","company_name":"ABBOTT LABORATORIES","filed_at":"2026-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.929071+00:00","generated_at":"2026-05-15T05:50:43.027807+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Abbott Q1 adj. EPS $1.15, +6% YoY; acquires Exact Sciences; FY guidance $5.38-$5.58","bullets":["Q1 GAAP diluted EPS $0.61; adjusted diluted EPS $1.15 (+6% YoY).","Q1 sales $11.16B, reported +7.8%, comparable +3.7%.","Completed Exact Sciences acquisition March 23; adds $0.20 dilution to FY EPS guidance.","FY2026 guidance: comparable sales growth 6.5%-7.5%; adjusted EPS $5.38-$5.58.","Medical Devices +8.5% comparable; Diabetes CGM +7.6% comparable; Nutrition -7.7% comparable."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-025365","json":"https://secwatch.observer/filing/0001628280-26-025365.json","markdown":"https://secwatch.observer/filing/0001628280-26-025365.md","text":"https://secwatch.observer/filing/0001628280-26-025365.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800/000162828026025365/0001628280-26-025365-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800/000162828026025365/abt-20260416.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:50:43.027807+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3c1b68443e4c7de69c282c93fbaff1e08f7aa7e6","claim":"ABBOTT LABORATORIES updated its first quarter ended March 31, 2026 guidance (reaffirmed).","evidence_excerpt":"On April 16, 2026, Abbott Laboratories announced its results of operations for the first quarter 2026.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800/000162828026025365/0001628280-26-025365-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}